SoftBank Group has ​reopened talks with a consortium of lenders for a $10 billion loan backed by its stake in OpenAI, after ...
In a recent decision, the Supreme Court has made it more difficult to hold U.S. corporations liable for complicity in human ...
A big part of the preparation focused on aligning the technology with the user experience we wanted. Lottu was designed ...
A judge scrutinizing the DOJ’s decision to drop a case is rare and brings the matter into largely uncharted waters, lawyers ...
FORT BELVOIR, Va. -- Reginald Shuford, project director for Consolidated Enterprise Resource Planning (C-ERP) and Lt. Col. Stephanie Williams, system director for Global Combat Support System-Army ...
Earlier this year, Peso Pluma — a 24-year-old who grew up in between Guadalajara, Jalisco, and San Antonio — became the first regional Mexican... Regional Goes Global, Part 1: Finding Peso Pluma's ...
Saks Global is laying off about 16% of its corporate staff as it seeks to emerge from bankruptcy protection later this year, according to a person familiar with the situation. About 640 jobs are being ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...
March 19 (Reuters) - Realty Income (O.N), opens new tab said on Thursday it will get $1 billion from asset manager ‌Apollo Global Management (APO.N), opens new tab and affiliates for a 49% interest in ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Erik Steiger discusses the operational pain ...
Tolerability profile supported by dosimetry and low-grade non-hematologic events. Lesion dosimetry indicates no difference in absorbed dose profile across cohorts. No adverse drug-drug interactions ...